hydrodilatation

Hydrodilatation is a minimally invasive procedure used to treat benign prostatic hyperplasia (BPH), a condition characterized by an enlarged prostate gland that can cause urinary symptoms such as difficulty urinating, frequent urination, and weak urine flow. The procedure involves the insertion of a thin, flexible tube called a hydrodilator into the urethra, which is then inflated with a saline solution. This inflation helps to widen the urethra, reducing the pressure on the prostate and improving urinary flow.

The hydrodilator is typically inserted through the penis, and the procedure is usually performed in a hospital or clinic setting under local anesthesia. The entire process typically takes about 15 to 30 minutes. Hydrodilatation is considered a safe and effective alternative to more invasive surgical procedures, such as transurethral resection of the prostate (TURP), and is often recommended for patients who are not suitable candidates for surgery or prefer a less invasive option.

Post-procedure, patients may experience some temporary side effects, such as blood in the urine, pain, or difficulty urinating, which usually resolve within a few days. Long-term benefits of hydrodilatation include improved urinary flow, reduced urinary frequency, and a decrease in the need for medications to manage BPH symptoms. However, the effectiveness of the procedure can vary among individuals, and some patients may require additional treatments or procedures to achieve optimal results.